Oncogenes, such as BRAF, PIK3CA and IDH1, showed individual nullomer emerging hotspots, whereas tumor suppressors such as TP53 showed dispersed patterns of nullomer emergence across the gene body (Fig. 3B). This evidence concerns the gene BRAF and neoplasm.